367 related articles for article (PubMed ID: 9662269)
21. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
22. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
[TBL] [Abstract][Full Text] [Related]
23. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
Yamada S; Asakura H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
[TBL] [Abstract][Full Text] [Related]
25. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
26. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
27. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
28. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
29. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
30. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
31. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
32. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
[TBL] [Abstract][Full Text] [Related]
34. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
35. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
36. Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura.
Sakai K; Wada H; Nakatsuka Y; Kubo M; Hayakawa M; Matsumoto M
J Intensive Care Med; 2021 Apr; 36(4):436-442. PubMed ID: 31964209
[TBL] [Abstract][Full Text] [Related]
37. [Clinical application of laboratory diagnosis: leukemia and DIC].
Deguchi K; Zhao LJ; Shirakawa S
Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
[TBL] [Abstract][Full Text] [Related]
38. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]